Skip to main content

Table 4 Proximity to any facility, the average annual dioxin emission index, and risk of non-Hodgkin Lymphoma: all NHL and by histological subtype

From: Residential proximity to industrial combustion facilities and risk of non-Hodgkin lymphoma: a case–control study

 

Never lived within distance

Ever lived within distance

Average annual emission index

Quartile 1

Quartile 2

Quartile 3

Quartile 4

 

Cases

Controls

OR (95%CI)a

Cases

Controls

OR (95%CI)a

Cases

Controls

OR (95%CI)a

Cases

Controls

OR (95%CI)a

Cases

Controls

OR (95%CI)a

Cases

Controls

OR (95%CI)a

5 km

                  

All NHL

595

459

1.0

374

290

1.0 (0.8-1.2)

97

73

1.0 (0.7-1.4)

102

72

1.1 (0.7-1.5)

85

73

0.9 (0.6-1.3)

90

72

1.0 (0.7-1.4)

DLBCL

182

459

1.0

122

290

1.0 (0.7-1.3)

30

73

1.0 (0.6-1.6)

28

72

0.9 (0.5-1.5)

32

73

1.0 (0.6-1.6)

32

72

1.0 (0.6-1.7)

Follicular

141

459

1.0

86

290

1.0 (0.7-1.4)

22

73

0.9 (0.5-1.6)

26

72

1.1 (0.7-1.9)

18

73

0.8 (0.4-1.5)

20

72

1.0 (0.5-1.7)

CLL/SLL

66

459

1.0

36

290

0.8 (0.5-1.3)

9

73

0.9 (0.4-2.0)

8

72

0.7 (0.3-1.6)

9

73

0.8 (0.3-1.7)

10

72

0.9 (0.4-1.9)

Marginal zone

57

459

1.0

25

290

1.1 (0.6-1.8)

5

73

0.5 (0.2-1.5)

10

72

1.5 (0.7-3.3)

2

73

0.5 (0.1-2.2)

8

72

2.6 (1.0-6.8)

Other subtypes

78

459

1.0

50

290

0.8 (0.5-1.3)

15

73

1.2 (0.6-2.3)

12

72

0.8 (0.4-1.6)

13

73

0.7 (0.3-1.5)

10

72

0.5 (0.2-1.2)

NOS lymphoma

71

459

1.0

55

290

1.4 (0.9-2.2)

16

73

1.4 (0.8-2.7)

18

72

1.8 (1.0-3.3)

11

73

1.1 (0.5-2.4)

10

72

1.1 (0.5-2.5)

3 km

                  

All NHL

754

579

1.0

215

170

1.0 (0.8-1.3)

67

43

1.2 (0.8-1.8)

39

42

0.7 (0.5-1.2)

52

43

0.9 (0.6-1.4)

57

42

1.1 (0.7-1.7)

DLBCL

235

579

1.0

69

170

0.9 (0.6-1.3)

22

43

1.2 (0.7-2.1)

11

42

0.6 (0.3-1.2)

14

43

0.7 (0.4-1.3)

22

42

1.2 (0.7-2.1)

Follicular

178

579

1.0

49

170

1.0 (0.6-1.4)

18

43

1.3 (0.7-2.5)

6

42

0.5 (0.2-1.1)

11

43

0.8 (0.4-1.7)

14

42

1.1 (0.6-2.2)

CLL/SLL

81

579

1.0

21

170

0.9 (0.5-1.6)

3

43

0.6 (0.2-1.9)

4

42

0.7 (0.2-2.0)

9

43

1.7 (0.7-3.7)

5

42

0.8 (0.3-2.3)

Marginal zone

66

579

1.0

16

170

1.3 (0.7-2.4)

3

43

0.7 (0.2-2.3)

4

42

1.3 (0.4-3.9)

3

43

1.1 (0.3-4.0)

6

42

3.0 (1.1-8.3)

Other subtypes

101

579

1.0

27

170

0.8 (0.5-1.3)

8

43

1.0 (0.5-2.3)

8

42

1.0 (0.4-2.2)

6

43

0.6 (0.3-1.6)

5

42

0.6 (0.3-2.5)

NOS lymphoma

93

579

1.0

33

170

1.5 (0.9-2.3)

13

43

2.1 (1.1-4.2)

6

42

1.1 (0.4-2.7)

9

43

1.5 (0.6-3.2)

5

42

0.9 (0.3-2.5)

  1. DLBCL = Diffuse large B-cell lymphoma; CLL/SLL = Chronic lymphocytic leukemia/small lymphocytic lymphoma; NOS lymphoma = not otherwise specified.
  2. a Adjusted for age (<35, 35–44, 45–54, 55–64, >65 yrs), gender, race (white, black, other/unknown), center (Detroit, Seattle, Iowa, Los Angeles), years of education (<12, 12–15, >16).